Abstract:Traumatic brain injuries (TBIs) constitute a significant public health issue and a major source of disability and death in the United States and worldwide. TBIs are strongly associated with high morbidity and mortality rates, resulting in a host of negative health outcomes and long-term complications and placing a heavy financial burden on healthcare systems. One promising avenue for the prevention and treatment of brain injuries is the design of TBI-specific supplementation and dietary protocols centred around nutraceuticals and biochemical compounds whose mechanisms of action have been shown to interfere with, and potentially alleviate, some of the neurophysiological processes triggered by TBI. For example, evidence suggests that creatine monohydrate and omega-3 fatty acids (DHA and EPA) help decrease inflammation, reduce neural damage and maintain adequate energy supply to the brain following injury. Similarly, melatonin supplementation may improve some of the sleep disturbances often experienced post-TBI. The scope of this narrative review is to summarise the available literature on the neuroprotective effects of selected nutrients in the context of TBI-related outcomes and provide an evidence-based overview of supplementation and dietary protocols that may be considered in individuals affected by—or at high risk for—concussion and more severe head traumas. Prophylactic and/or therapeutic compounds under investigation include creatine monohydrate, omega-3 fatty acids, BCAAs, riboflavin, choline, magnesium, berry anthocyanins, Boswellia serrata, enzogenol, N-Acetylcysteine and melatonin. Results from this analysis are also placed in the context of assessing and addressing important health-related and physiological parameters in the peri-impact period such as premorbid nutrient and metabolic health status, blood glucose regulation and thermoregulation following injury, caffeine consumption and sleep behaviours. As clinical evidence in this research field is rapidly emerging, a comprehensive approach including appropriate nutritional interventions has the potential to mitigate some of the physical, neurological, and emotional damage inflicted by TBIs, promote timely and effective recovery, and inform policymakers in the development of prevention strategies.

Traumatic brain injury: Symptoms to systems in the 21st century

'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope

Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury

Beyond the Brain: Peripheral Interactions after Traumatic Brain Injury

Non-pharmacological interventions for traumatic brain injury

Colloidal therapeutics in the management of traumatic brain injury: Portray of biomarkers and drug-targets, preclinical and clinical pieces of evidence and future prospects

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets

The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapies

Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs

Biomarkers and New Pharmacological Targets

Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Impaired autophagic flux in the human brain after traumatic brain injury

Neuroimmune and Neuroinflammation Response for Traumatic Brain Injury

The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury

Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols

The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury

Therapy of traumatic brain injury by modern agents and traditional Chinese medicine

Multifunctional Nanoparticles and Nanoclusters as a Theranostics and Symptoms Disappearing Agent for Traumatic Brain Injury

Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities